Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cellsWeiqing Jing, Qizhen Shi, Feng Xue et al.|Journal of Thrombosis and Haemostasis|2023Cited by 4